The AWS SDK for Java enables Java developers to easily work with Amazon Web Services and build scalable solutions with Amazon S3, Amazon DynamoDB, Amazon Glacier, and more. See the AWS SDK for Java ...

Get the latest Orchasp share price today on NSE & BSE. Explore Orchasp stock analysis, financial performance, market capitalization, dividend history, and future outlook for investors in India.

Dr Reddy’s Laboratories share price falls over 5% after Health Canada notice on Semaglutide ANDS filing. (Image: Canva) The Dr Reddy’s share price plunged 5.6% to an intra-day low of Rs 1,180.90 on ...

Shares of Dr. Reddy's Laboratories fell over 4% in early trading on Thursday, October 30, after the approval for its Semaglutide injection was delayed. The company has received the Notice of ...

Dr. Reddy's Laboratories Limited RDY reported second-quarter fiscal 2026 earnings of 19 cents per American Depositary Share (ADS), which beat the Zacks Consensus Estimate of 18 cents. The company ...

Sandeep Reddy Vanga commemorated the eighth anniversary of his directorial debut, Arjun Reddy, acknowledging its profound impact on his life and career. He expressed gratitude to the cast, crew, and ...

Pharma major Dr. Reddy's Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1,418 crore for the first quarter ended June. Revenue from operations rose ...

Andhra Pradesh is covered in a political storm after former YSRCP MLA Nallapareddy Prasanna Kumar Reddy made derogatory comments against the sitting Kovuru MLA, Vemireddy Prashanthi Reddy. The ...

Sandeep Reddy Vanga needs no introduction. The director is known for films like Arjun Reddy, Kabir Singh, and Animal. He is often accused of presenting women in his films in the wrong way and is also ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Membership (fee-based) Ashok Reddy is CEO of KX, a leading high-performance analytical ...

Pharmaceutical layoffs planned? No, says Dr Reddy's Laboratories, as the drugmaker categorically denied media reports that has undertaken workforce reduction to cut costs by around 25 per cent.